Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Authors
Keywords
Passive immunization, Dementia, Therapeutic antibodies, Effector function, Oligomers, ADDLs, Protofibrils, Regulatory strategy
Journal
Immunity & Ageing
Volume 10, Issue 1, Pages 18
Publisher
Springer Nature
Online
2013-05-12
DOI
10.1186/1742-4933-10-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
- (2013) Ting Yang et al. Alzheimers & Dementia
- Globular and Protofibrillar Aβ Aggregates Impair Neurotransmission by Different Mechanisms
- (2013) Jens Moreth et al. BIOCHEMISTRY
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Amyloid-β Immunotherapy for Alzheimers Disease
- (2012) H.J. Fu et al. CNS & Neurological Disorders-Drug Targets
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- ARIA from off-key operas?
- (2012) Giovanni B Frisoni LANCET NEUROLOGY
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Naturally Occurring Autoantibodies against -Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
- (2011) R. Dodel et al. JOURNAL OF NEUROSCIENCE
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
- (2010) Inna Kuperstein et al. EMBO JOURNAL
- Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species
- (2010) Asad Jan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid -Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
- (2010) B. O'Nuallain et al. JOURNAL OF NEUROSCIENCE
- Generation and Therapeutic Efficacy of Highly Oligomer-Specific -Amyloid Antibodies
- (2010) H. Hillen et al. JOURNAL OF NEUROSCIENCE
- Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
- (2010) Mahiuddin Ahmed et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cognitive effects of cell-derived and synthetically derived Aβ oligomers
- (2010) Miranda N. Reed et al. NEUROBIOLOGY OF AGING
- HH Domain of Alzheimer’s Disease Aβ Provides Structural Basis for Neuronal Binding in PC12 and Mouse Cortical/Hippocampal Neurons
- (2010) Joseph F. Poduslo et al. PLoS One
- The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?
- (2010) Kerensa Broersen et al. Alzheimers Research & Therapy
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease
- (2009) M. Britschgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Structure – Function Relationships of Pre-Fibrillar Protein Assemblies in Alzheimers Disease and Related Disorders
- (2008) F. Rahimi et al. Current Alzheimer Research
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
- Peripheral A subspecies as risk biomarkers of Alzheimer's disease
- (2008) N. Schupf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started